Aragen Life Sciences (Aragen), formerly known as GVK Biosciences and a leading contract research organization (CRO), announced that Goldman Sachs, an active investor in India, has taken a significant minority stake in the company by acquiring shares previously held by ChrysCapital and other existing shareholders. Aragen is a leading provider of outsourced discovery, development, and…